Cargando...
Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer
Due to the lack of a definite diagnosis, a frequent recurrence rate and resistance to chemotherapy or radiotherapy, the clinical outcome for patients with advanced laryngeal cancer has not improved over the last decade. Annexin A2 is associated with the invasion and metastasis of cancer cells. In th...
Gardado en:
| Publicado en: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740805/ https://ncbi.nlm.nih.gov/pubmed/29285166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5298 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|